Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
6917 participants
INTERVENTIONAL
2025-02-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
NCT05865184
Electronic Patient Reported Outcome (ePRO) Mobile Application Pragmatic Trial
NCT02917954
Developing Enhanced Prediction Models
NCT02983812
Deployment of American Heart Association Heart Failure Protocols and Content Within the Intel® Health Guide System
NCT01275846
Evaluation of the Performance of an e-Health System
NCT02803489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Implementation at Vanderbilt University Medical Center (VUMC) & Vanderbilt Wilson County Hospital
ePNa (the decision support tool) will be implemented at 2 EDs that are part of the Vanderbilt Health system.
ePNa
Real-time, automated clinical decision support tool for pneumonia (called "ePNa")
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ePNa
Real-time, automated clinical decision support tool for pneumonia (called "ePNa")
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2500 patients that presented to the Vanderbilt and Wilson county EDs who are \>= 18 years old will be identified by ICD-10 codes for pneumonia or acute respiratory failure or sepsis with secondary pneumonia codes for the baseline database.
* An additional 2500 patients that presented to the Vanderbilt and Wilson county EDs who are \>= 18 years old will be identified by having had conventional PA (posteroanterior) and lateral or portable CXRs (chest X-rays), independent of ICD-10 codes.
* During the one year pilot trial, patients seen in the 2 EDs, who are \>= 18 years old will be identified by ICD(International Classification of Diseases)-10 codes for pneumonia or acute respiratory failure or sepsis with secondary pneumonia codes (estimated to comprise 1800 patients).
Exclusion Criteria
1. Patients seen with a history of recent trauma.
2. Subsequent episodes of pneumonia from the same patient within the study period.
3. Patients directly admitted to hospice/comfort care.
4. Patients admitted to a non-study hospital for further care.
5. Patients transferred from outside hospitals.
For the groups selected by ICD-10 pneumonia codes, an additional exclusion is:
• Patients without radiographic evidence of pneumonia or with clear radiographic evidence for an alternative diagnosis.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Vanderbilt University
OTHER
Stanford University
OTHER
Nathan Dean
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nathan Dean
Professor, Pulmonary and Critical Care Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathan Dean, MD
Role: PRINCIPAL_INVESTIGATOR
Intermountain Health
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1052404
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.